Description
Tirzepatide is a synthetic peptide research compound that engages both the GIP and GLP-1 receptors as a dual agonist. It is studied as a probe for combined incretin signaling.
Published preclinical work in cell and animal systems has looked at glucose balance, insulin secretion, appetite-related endpoints, and simultaneous activation of two incretin receptors. Its dual-target design supports research into receptor cooperation.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.